27 September 2024 Antibody-drug conjugates (ADCs) represent a significant advancement in cancer treatment, particularly within China's burgeoning oncology sector.
Shares of German pharma major Bayer were up 4.6% at 30.45 euros after it released positive early trial results for its Parkinson’s disease candidate. 27 September 2024
Shionogi said today that it has submitted a New Drug Application (NDA) in Japan for zuranolone, a treatment in development for major depressive disorder (MDD). 27 September 2024
CNS specialist Lundbeck has announced data from the TALISMAN natural history study, as well as additional data from the AMULET trial, of amlenetug, in multiple system atrophy (MSA) at the International Congress of Parkinson's Disease and Movement disorders in Philadelphia, USA. 27 September 2024
Repair Biotechnologies, a company developing therapies to reverse atherosclerotic plaque, has entered into a collaboration with Genevant Sciences, a specialist in nucleic acid delivery technology. 27 September 2024
China’s National Medical Products Administration (NMPA) has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD). 27 September 2024
Chicago, USA-based ARCH Venture Partners revealed it has closed the ARCH Venture Fund XIII, a venture capital fund with more than $3 billion to support the founding and growth of early-stage biotechnology companies. 27 September 2024
US virology and immunology company Enanta Pharmaceuticals has given further weight to its claims to have the leading portfolio of potent respiratory syncytial virus (RSV) replication inhibitors 27 September 2024
Sage Therapeutics has announced that Biogen has terminated its partnership on the SAGE-324 program, following the recent failure of the drug in a Phase II study for the treatment of essential tremor. 27 September 2024
A US Food and Drug Administration advisory committee meeting has recommended restricting the use of PD-1 inhibitors, in a move which could affect blockbuster products such as Bristol Myers Squibb's Opdivo (nivolumab) and Merck & Co's Keytruda (pembrolizumab). 27 September 2024
The US Food and Drug Administration yesterday approved pharma major Bristol Myers Squibb’s Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. 27 September 2024
USA-based biotech funder and incubator Flagship Pioneering yesterday unveiled Mirai Bio, a company pioneering the first open end-to-end platform for the biotech industry to enable the co-creation of fully optimized genetic medicines. 27 September 2024
Antibody-drug conjugates (ADCs) represent a significant advancement in cancer treatment, particularly within China's burgeoning oncology sector. 27 September 2024
US drugmaker AbbVie has announced positive topline results from its pivotal Phase III TEMPO-1 trial for tavapadon as a monotherapy in early Parkinson's disease. 26 September 2024
Evaxion Biotech has entered into an option and license agreement with MSD (tradename of Merck & Co outside of the USA and Canada), for two pre-clinical vaccine candidates. 26 September 2024
Danish CNS specialist Lundbeck and US privately-held biotech Iambic Therapeutics today announced a strategic research collaboration to focus on discovery of a small molecule therapeutic for the treatment of migraine. 26 September 2024
The generics and biosimilars trade group, Medicines for Europe, has put out a strong message amid ongoing discussions on a European Union (EU) Critical Medicines Act. 26 September 2024
Pfizer (NYSE: PFE) has announced the withdrawal of Oxbryta (voxelotor), a treatment for sickle cell disease (SCD), from all global markets. 26 September 2024
Belgium biopharma UCB has announced positive top-line interim analysis results showing that the Phase III BE MOBILE 1 study met the primary and all ranked secondary endpoints. 18 January 2022
The US Food and Drug Administration has extended the review period for the biologics licensing applications (BLA) for its lentiviral vector gene therapies – betibeglogene autotemcel (beti-cel) for β-thalassemia and elivaldogene autotemcel (eli-cel) for cerebral adrenoleukodystrophy (CALD), submitted by bluebird bio, whose shares dived more than 11% to $8.27. 18 January 2022
French hearing loss specialist Sensorion saw its share plummet 42% yesterday, when it announced disappointing research results, and a further 13.7% to 0.91 euros today. 18 January 2022
Cell and gene therapy (CGT) manufacturing technology company Ori Biotech has secured more than $100 million in an oversubscribed Series B funding round. 18 January 2022
So-called ‘pharma bro’ Martin Shkreli has been held liable for antitrust claims brought by the US Federal Trade Commission (FTC) and a group of seven state enforcers. 18 January 2022
Spanish dermatology focussed drugmaker Almirall and IRB Barcelona (the Institute for Biomedicine) today announced a research collaboration to identify new oral treatments for immune-inflammatory skin diseases with remaining high unmet medical needs using molecular glue degraders, a novel therapeutic modality. 18 January 2022
The leading developer of vaccines and therapeutics for coronavirus disease, Pfizer, is to build new facilities in France as part of a near-$600 million investment in production of Paxlovid (nirmatrelvir/ritonavir). 18 January 2022
After an early decline, shares of UK-headquartered pharma services and products company Clinigen Group closed unchanged at 898.00 pence yesterday, after the company agreed higher take-private bid from Triton Investment Management, via Triley Bidco. 18 January 2022
German biotech Evotec has entered into a drug discovery collaboration with Eli Lilly in the field of metabolic diseases with a focus on kidney diseases and diabetes. 18 January 2022
In its latest analysis 2021 Review & Outlook for 2022, The Biotech Growth Trust reveals that now is an ideal time to buy small-cap biotech stocks for long-term investors, with many companies now trading at prices lower than the net cash on their balance sheet. 17 January 2022
US biopharma Adagio Therapeutics has summarized recent findings reported in three separate publications that show ADG20, its lead monoclonal antibody (mAb), has neutralization activity against the Omicron variant of SARS-CoV-2, and outlined initiatives to address current and future SARS-CoV-2 variants of concern. 17 January 2022
Even as Pfizer said it is redesigning a COVID-19 vaccine that specifically targets the Omicron coronavirus variant and is ready to launch the same by March, India could soon have its first messenger or mRNA vaccine targetting Omicron. 17 January 2022
London-listed Jordanian drugmaker Hikma Pharmaceuticals has agreed to acquire the Canadian assets of Teligent for $45.75 million. The transaction is expected to be completed before the end of the first quarter of 2022. 17 January 2022
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today launched a public consultation on a set of far-reaching proposals to improve and strengthen the UK clinical trials legislation to make the UK the best place to research and develop safe and innovative medicines. 17 January 2022
The US Food and Drug Administration has accepted the supplemental Biologics License Application (sBLA) of Enhertu (trastuzumab deruxtecan) for the treatment of adult patients in the US with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen. 17 January 2022
Shares of UK drugmaker GlaxoSmithKline were up 4.8% at 1,721.11 pence in early trading today, as the company rejected an unsolicited offer on Saturday for its Consumer Healthcare business, which could have been the biggest pharma M&A deal for several years. 17 January 2022
Newly-formed infectious diseases specialist Poolbeg Pharma has in-licenced a novel, first-in-class RNA-based immunotherapy from the University of Warwick. 17 January 2022
Dermavant Sciences, an immuno-dermatology-focused subsidiary of Switzerland-based Roivant Sciences, has released positive data from a patient satisfaction questionnaire related to tapinarof. 17 January 2022